T1	Intervention 172 445	The aim of the study was to investigate the influence of 40 mg of the beta-blocker penbutolol (Betapressin TM; Hoechst Ltd., Frankfurt/Main) in comparison to placebo on the insulin consumption on the blood sugar profile in twelve insulin-dependent diabetes (IDDM) patients.
T2	Intervention 1070 1080	parameters
T3	Intervention 74 85	consumption
